Binding molecules against sars-coronavirus and uses thereof

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/10 (2006.01) A61K 39/215 (2006.01) A61P 31/14 (2006.01) C12N 5/10 (2006.01) C12N 15/13 (2006.01) C12N 15/63 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2531684

The present invention provides binding molecules that specifically bind to SARS-CoV, nucleic acid molecules encoding the binding molecules, compositions comprising the binding molecules and methods of identifying or producing the binding molecules. The binding molecules are capable of specifically binding to SARS-CoV and can be used in the diagnosis, prophylaxis and/or treatment of a condition resulting from SARS-CoV.

L'invention concerne des molécules de liaison qui se lient spécifiquement au coronavirus du syndrome respiratoire aigu sévère (SARS-CoV), des molécules d'acide nucléique codant pour les molécules de liaison, des compositions comprenant ces molécules et des procédés d'identification ou de production desdites molécules. Les molécules de liaison peuvent se lier spécifiquement au SARS-CoV et peuvent servir à diagnostiquer, à prévenir et/ou à traiter un trouble engendré par le SARS-CoV.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Binding molecules against sars-coronavirus and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Binding molecules against sars-coronavirus and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Binding molecules against sars-coronavirus and uses thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1414241

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.